File Download
 
 
Supplementary

Conference Paper: Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract)
  • Basic View
  • Metadata View
  • XML View
TitleEfficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract)
 
AuthorsYau, TCC
Chan, P
Cheung, FY
Lee, AS
Yau, TK
Choo, SP
Toh, HC
Leung, AK
Wong, JS
Wong, S
Lau, J
Pang, RWC
Fan, ST
Poon, RTP
 
Issue Date2011
 
CitationThe 7th International Meeting Hepatocellular Carcinoma Eastern and Western Experiences, Paris, France, 14-15 January 2011 [How to Cite?]
 
DC FieldValue
dc.contributor.authorYau, TCC
 
dc.contributor.authorChan, P
 
dc.contributor.authorCheung, FY
 
dc.contributor.authorLee, AS
 
dc.contributor.authorYau, TK
 
dc.contributor.authorChoo, SP
 
dc.contributor.authorToh, HC
 
dc.contributor.authorLeung, AK
 
dc.contributor.authorWong, JS
 
dc.contributor.authorWong, S
 
dc.contributor.authorLau, J
 
dc.contributor.authorPang, RWC
 
dc.contributor.authorFan, ST
 
dc.contributor.authorPoon, RTP
 
dc.date.accessioned2011-07-27T02:02:43Z
 
dc.date.available2011-07-27T02:02:43Z
 
dc.date.issued2011
 
dc.identifier.citationThe 7th International Meeting Hepatocellular Carcinoma Eastern and Western Experiences, Paris, France, 14-15 January 2011 [How to Cite?]
 
dc.identifier.hkuros188330
 
dc.identifier.urihttp://hdl.handle.net/10722/136093
 
dc.languageeng
 
dc.relation.ispartofThe 7th International Meeting Hepatocellular Carcinoma Eastern and Western Experiences, Paris, France, 14-15 January 2011
 
dc.titleEfficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract)
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Yau, TCC</contributor.author>
<contributor.author>Chan, P</contributor.author>
<contributor.author>Cheung, FY</contributor.author>
<contributor.author>Lee, AS</contributor.author>
<contributor.author>Yau, TK</contributor.author>
<contributor.author>Choo, SP</contributor.author>
<contributor.author>Toh, HC</contributor.author>
<contributor.author>Leung, AK</contributor.author>
<contributor.author>Wong, JS</contributor.author>
<contributor.author>Wong, S</contributor.author>
<contributor.author>Lau, J</contributor.author>
<contributor.author>Pang, RWC</contributor.author>
<contributor.author>Fan, ST</contributor.author>
<contributor.author>Poon, RTP</contributor.author>
<date.accessioned>2011-07-27T02:02:43Z</date.accessioned>
<date.available>2011-07-27T02:02:43Z</date.available>
<date.issued>2011</date.issued>
<identifier.citation>The 7th International Meeting Hepatocellular Carcinoma Eastern and Western Experiences, Paris, France, 14-15 January 2011</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/136093</identifier.uri>
<language>eng</language>
<relation.ispartof>The 7th International Meeting Hepatocellular Carcinoma Eastern and Western Experiences, Paris, France, 14-15 January 2011</relation.ispartof>
<title>Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract)</title>
<type>Conference_Paper</type>
<identifier.hkuros>188330</identifier.hkuros>
</item>